Showing 1 - 4 results of 4 for search 'Sradha S', query time: 0.03s Refine Results
  1. 1
    Chitosan Nanoparticle-Mediated Delivery of <i>Alstonia venenata</i> R.Br. Root Methanolic Extract: A Promising Strategy for Breast Cancer Therapy in DMBA-Induced Breast Cancer in Sprague Dawley Rats

    Chitosan Nanoparticle-Mediated Delivery of <i>Alstonia venenata</i> R.Br. Root Methanolic Extract: A Promising Strategy for Breast Cancer Therapy in DMBA-Induced Breast Cancer in S... by Aarthi Jeganathan, Karuppusamy Arunachalam, Anju Byju, Anju Rani George, Sradha Sajeev, Kavimani Thangasamy, Geetha Natesan

    Published 2024-12-01
    Get full text
    Article
  2. 2
    Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care dataResearch in context

    Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collec... by Brendon L. Neuen, Min Jun, James Wick, Sradha Kotwal, Sunil V. Badve, Meg J. Jardine, Martin Gallagher, John Chalmers, Kellie Nallaiah, Vlado Perkovic, David Peiris, Anthony Rodgers, Mark Woodward, Paul E. Ronksley

    Published 2024-02-01
    Get full text
    Article
  3. 3
    SAFety, Effectiveness of care and Resource use among Australian Hospitals (SAFER Hospitals): a protocol for a population-wide cohort study of outcomes of hospital care

    SAFety, Effectiveness of care and Resource use among Australian Hospitals (SAFER Hospitals): a protocol for a population-wide cohort study of outcomes of hospital care by Martin Gallagher, Billingsley Kaambwa, Ian A Scott, Steven Guthridge, Renuka Visvanathan, Isuru Ranasinghe, Sadia Hossain, Anna Ali, Dennis Horton, Robert JT Adams, Bernadette Aliprandi-Costa, Christina Bertilone, Gustavo Carneiro, Sradha Kotwal, Gerry O'Callaghan, Richard J Woodman

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial

    Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial by Mark Jones, Gagandeep Kang, Thomas L Snelling, Vivekanand Jha, Vinay Rathore, Stephane Heritier, Meg Jardine, Kapil Soni, James Totterdell, Sradha Kotwal, Guy Thwaites, Cheryl Jones, Carol Pollock, Richard Haynes, Katrina Diamante, Abhinav Bassi, Nikita Bathla, Natalie Staplin, Arlen Wilcox, Ashpak Bangi, Gregory Fox, Atul Jindal, Rui Xie, Daniel Vincent O'Hara, Sanjay D'Cruz, Manish Kumar Jain, Louise Burrell, Sharifah Faridah Syed Omar, Gerard Estivill Mercade, Aishwarya Nair, Annelise Decaria, Nicola Abignano, Sabah Siddiqui, Suprava Patel, Anjulata Sahu, Yasmeen Shaikh, Madhavender Jain, Shivam R Kanje, Sanjeev Kumar Vimal, K. Kalyan Chakravarthy, P. Sathish Babu, Yuvraj Singh Cheema, Merlin Moni, Sivapriya G Nair

    Published 2024-10-01
    Get full text
    Article

Search Tools: